Abstract
We have explored the effects of enteral nutrition interventions on the analgesic effect of morphine hydrochloride sustained-release tablets in cancer pain therapy. Patients in the control group were monitored in real time, and analgesics were given as needed to improve the pain. Patients in the treatment group received both morphine hydrochloride sustained-release tablets and enteral nutrition interventions. After treatment, the Visual Analogue Scale score, unified Parkinson’s disease rating scale, and Pittsburgh sleep quality index scores in the treatment group were reduced relative to the control group, and Parkinson’s disease sleep scale scores and nutritional indexes were elevated. Levels of interferon-γ and interleukin-2 in the treatment group were elevated relative to the control group, while the levels of interleukin-4 were reduced. The incidence of adverse reactions in the treatment group was 15.79% (21/133), which was lower relative to the control group (31.58%, 42/133). Levels of 5-hydroxytryptamine and brain-derived neurotrophic factor in the treatment group were elevated relative to the control group, while the levels of dopamine declined. To sum up, morphine hydrochloride sustained-release tablets combined with enteral nutrition interventions can decrease the inflammatory response of patients and promote sleep quality
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
